Abstract
This study was undertaken to pharmacokinetically evaluate the efficacy of direct hemoperfusion under hepatic venous isolation (HVI-DHP) to cisplatin (CDDP) removal during hepatic arterial infusion. CDDP (2–4 mg/kg) was administered continuously to mongrel dogs through the hepatic artery for 10 min. Plasma levels and tissue concentrations were then compared between animals receiving CDDP alone (group 1, n=4) and those treated with additional HVI-DHP for 20 min (group 2, n=6). The peak CDDP levels in the right external jugular vein (systemic level) were 6.10±1.31 (mean±SD) and 1.41±0.12 μg/ml in groups 1 and 2 at a dosage of 2 mg/kg, respectively (P<0.01). The estimated drug removal rates in group 2 animals at dosages of 2 and 4 mg/kg were 45.7 (mean, n=5) and 46.9% (n=1), respectively. The tissue concentrations of CDDP of the liver 30 min after the initiation of infusions were similar in both groups. The values of the liver, the heart, and the kidney were 1.90±0.55, 0.50±0.16, and 3.90±2.50 μg/g of wet tissue weight, respectively, in group 1. In contrast, tissue levels of the heart and the kidney in group 2 animals were significantly reduced, with the values at a dosage of 2 mg/kg being 0.21±0.03 μg/g (P<0.01) and 0.86±0.53 μg/g (P<0.05), respectively. This study demonstrated that the extrahepatic distribution of CDDP during hepatic arterial infusion can be reduced significantly by the concomitant use of HVI-DHP.
Similar content being viewed by others
References
Creech O Jr, Krementz ET, Ryan RD, Winblad JN (1958) Chemotherapy of cancer: Regional perfusion utilizing an extracorporeal circuit. Ann Surg 48:616–632
Aigner KR, Walther H, Link KH (1988) Isolated liver perfusion with MMC/5-FU: Surgical technique, pharmacokinetics, clinical results. Contrib Oncol 29:229–46
Ku Y, Saiton M, Nishiyama H, Fujiwara S, Iwasaki T, Tominaga M, Maekawa Y, Ohyanagi H, Saitoh Y (1990) Extracorporeal removal of anticancer drugs in hepatic artery infusion: The effect of direct hemoperfusion combined with venous bypass. Surgery 107:273–281
Miller RG, Doerger JU (1975) Determination of platinum and palladium in biological samples. At absorpt news 14:66–77
Ku Y, Saitoh M, Fujiwara S, Iwasaki T, Nishiyama H, Tominaga M, Maekawa Y, Kasahara H, Ohyanagi M, Sako M, Saitoh Y (1990) A new method of intra-arterial high dose chemotherapy for unresectable hepatocellular carcinoma — The effect of direct hemoperfusion under hepatic venous isolation. (in Japanese with English Abstract) Nippon Shokakibyo Gakkai Zasshi (Jpn J Gastroenterol Soc) 87:1864–1872
Yagoda A, Johnson DE, Samuels ML (1979) Phase II trials in bladder cancer at Memorial Sloan-Kettering Cancer Center, 1975–1978. Cancer of the genitourinary tract. Raven Press New York, pp 107–119
Kajanti M, Rissanen P, Virkkunen P, Franssila K, Mantyia M (1986) Regional intra-arterial infusion of cisplatin in primary hepatocellular carcinoma. Cancer 58:2386–2388
Alan GW, Kar R, Cohen RA, Jakowatz JG, Opfell RW (1987) The pharmacokinetics of cisplatin in experimental regional chemotherapy. Cancer 59:695–700
Stewart DJ, Benjamin RS, Zimmerman S, Caprioli RM, Wallence S, Chuang V, Calvo III D, Samuels M, Bonura J, Loo TL (1983) Clinical pharmacology of intra-arterial cis-Diamminedichloroplatinum (II). Cancer Res 143:917–920
Ozawa S, Sugiyama Y, Mituhashi J, Inaba M (1989) Kinetic analysis of cell killing effect induced by cytosine arabinoside and cisplatin in relation to cell cycle phase specificity in human colon cancer and Chinese hamster cells. Cancer Res 49:3823–3828
Glen R, Howele JA, Walker EM (1971) Antitumor and antimitotic properties of cis-dichloroplatinum (II). Cancer Res 31:950–952
Bitran JD, Desser RK, Billings AA, Kozloff MF, Shapiro CM (1977) Acute nephrotoxicity following cisdichlorodiamine-platinum. Cancer 49:1784–1788
Hayes DM, Cvitkovic E, Golbey RB, Scheiner E, Helson L, Krakoff IH (1977) High dose cis-platinum diamine dichloride. Cancer 39:1372–1381
Manaka RC, Wolf W (1987) Distribution of cisplatin in blood. Chem Biol Interact 22:353–358
Litterst CL, Gram TE, Dedrick RL, Leroy AF, Guarino AM (1976) Distribution and deposition of platinum following intravenous administration of cis-diaminedichloroplatinum (II) (NSC119875) to dogs. Cancer Res 36:2340–2344
Nakadate H, Kobayashi R, Nishi M, Hatae Y, Takeda T. The residual concentration of cis-platinum in autopsied tissue and pathological damage of kidney due to cis-platinum (in Japanese with English Abstr.) Nippon Shonika Gakkai Zasshi (Jpn J Pediat Soc) 1987; 91:3303–3306
Nakao I (1986) Hepatic failure and renal failure in antineoplastic chemotherapy, and its treatment. (in Japanese) Gan to Kagaku Ryoho 13:2930–2938
Sasaki Y, Imaoka S, Iwanaga T, Miyoshi Y, Kasugai H, Kojima J, Tanaka S, Fujita M, Kawamoto S, Ishuro S (1986) New approach of chemoembolization for hepatocellular carcinoma. (in Japanese) Nippon Kagaku Ryoho Gakkai Zasshi (Chemotherapy) 21:647–654
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maekawa, Y., Ku, Y. & Saitoh, Y. Extracorporeal cisplatin removal using direct hemoperfusion under hepatic venous isolation for hepatic arterial chemotherapy: An experimental study on pharmacokinetics. Surg Today 23, 58–62 (1993). https://doi.org/10.1007/BF00309001
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00309001